Vitalhub (TSE:VHI – Get Free Report) was upgraded by research analysts at TD Securities to a “strong-buy” rating in a report released on Monday,Zacks.com reports.
Separately, Cormark lifted their price target on Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a research report on Wednesday, October 2nd.
Read Our Latest Research Report on Vitalhub
Vitalhub Stock Up 0.9 %
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- How to Invest in Biotech Stocks
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Investing in Construction Stocks
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Business Services Stocks Investing
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.